Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability

by Sartorius Stedim Spain

5 years ago
life science, profitability, Sartorius, results, Bioprocess Solutions Division

The life science group Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related...

Sartorius Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing

by Sartorius Stedim Spain

5 years ago
stem cells, regenerative medicine, life science, Gene Therapy, RoosterBio

The life science company Sartorius signed a strategic collaboration with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media a...

Sartorius to acquire Novasep’s chromatography process equipment division

by Sartorius Stedim Spain

6 years ago
insulin, peptides, molecules, Novasep, chromatography process equipment

The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.

Sartorius refinances syndicated loan and increases financing flexibility

by Sartorius Stedim Spain

6 years ago
credit line, loan, bank, life science, strong growth

The life science group Sartorius refinanced its syndicated loan, increasing it to 600 million euros. The company signed a loan agreement with an international bank syndicate led by BNP Paribas, Commer...

Sartorius acquires filtration expert WaterSep BioSeparations

by Sartorius Stedim Spain

6 years ago
gene therapy, Sartorius, WaterSep BioSeparations, biopharmaceutical applications, cell therapy

The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.

Sartorius and Evotec partner with start-up Curexsys on iPSC-based therapeutic exosome approach

by Sartorius Stedim Spain

6 years ago
GMP, Curexsys, exosome, immune, antibody, regenerative therapies, Sicca Syndrome

Evotec SE and the life science company Sartorius announced today that they have entered into a partnership with the recently established Curexsys GmbH, a Goettingen, Germany-based technology leader sp...

Sartorius pays employees a coronavirus bonus

by Sartorius Stedim Spain

6 years ago
employees, coronavirus, Sartorius, bonus

The life science company Sartorius will pay a total of around ten million euros in coronavirus bonuses to its employees in appreciation of their extraordinary commitment and special achievements.

Sartorius closes acquisition of BIA Separations

by Sartorius Stedim Spain

6 years ago
life science, Sartorius, BIA Separations, gene therapies

The life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the ...

Sartorius to open new Customer Interaction Center in North America

by Sartorius Stedim Spain

6 years ago
Customer Interaction Center, Sartorius, life science, biopharmaceutical

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is expanding its presence in Massachusetts with a North American Customer Interaction Center. Sa...

Strong profitable growth at Sartorius

by Sartorius Stedim Spain

6 years ago
biopharmaceutical industry, Bioprocess Solutions Division, Sartorius, profitable

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, closed the first nine months of 2020 with significant double-digit growth rates in sales revenue...

Purification specialist BIA Separations to become part of Sartorius

by Sartorius Stedim Spain

6 years ago
cell therapeutics, gene therapeutics, BIA Separations, Sartorius Stedim

The life science company Sartorius announced today it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transacti...

AI for biopharmaceutical production – Sartorius a new shareholder in DFKI, the German Research Center for Artificial Intelligence

by Sartorius Stedim Spain

6 years ago
medicine, biopharmaceutical, Artificial Intelligence, DFKI, pharma

Sartorius has joined the group of shareholders of the German Research Center for Artificial Intelligence (DFKI). The Göttingen-based life science group and DFKI have already been working together for...